45 related articles for article (PubMed ID: 35359046)
1. [Prevalence and frequencies of human papilloma virus types in adenocarcinoma in situ of the uterine cervix].
Jin J; Luo RK; Zhao J; Ning YQ; Qu X; Tao XR; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2022 Apr; 51(4):338-343. PubMed ID: 35359046
[No Abstract] [Full Text] [Related]
2. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
Song F; Du H; Wang C; Huang X; Wu R;
PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
[TBL] [Abstract][Full Text] [Related]
3. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
[TBL] [Abstract][Full Text] [Related]
4. Interest of cytology combined with Xpert
Nassereddine H; Charpentier C; Bucau M; Joly V; Bienvenu L; Davitian C; Abramowitz L; Benabderrahmane D; Kotelevets L; Chastre E; Lehy T; Walker F
HIV Med; 2018 Nov; 19(10):698-707. PubMed ID: 30062761
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix.
Stuebs FA; Gass P; Dietl AK; Schulmeyer CE; Adler W; Geppert C; Hartmann A; Knöll A; Beckmann MW; Koch MC
Arch Gynecol Obstet; 2021 Sep; 304(3):751-758. PubMed ID: 33538863
[TBL] [Abstract][Full Text] [Related]
6. HIGH-RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?
Kares S; Veijalainen O; Kholová I; Tirkkonen M; Vuento R; Huhtala H; Tuimala V; Mäenpää J; Kujala P
APMIS; 2019 Nov; 127(11):710-716. PubMed ID: 31403733
[TBL] [Abstract][Full Text] [Related]
7. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of combined high-grade squamous intraepithelial lesion and adenocarcinoma in situ of the uterine cervix: human papillomavirus genotype and methylation status and immunohistochemical study.
Kawakami F; Semba S; Itami H; Oka N; Sudo T; Ebina Y; Ohbayashi C; Mikami Y; Yokozaki H; Itoh T
Kobe J Med Sci; 2014 Nov; 60(3):E66-73. PubMed ID: 25612672
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high-risk human papillomavirus and cervical lesion risk factors: A population-based study in Zhejiang, China 2010-2019.
Lu W; Chen T; Yao Y; Chen P
J Med Virol; 2021 Aug; 93(8):5118-5125. PubMed ID: 33913528
[TBL] [Abstract][Full Text] [Related]
10. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
Alexander C; White M; Maleki Z; Rodriguez EF
Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
[TBL] [Abstract][Full Text] [Related]
11. [Clinical effect evaluation of high risk human papilloma virus E6/E7 mRNA in triaging women with atypical squamous cells of undetermined significance].
Guo Z; Zhao DM; Zhang SK; Wu ZN; Sun XB; Jia MM; Chen Q; Guo LW; Chen PP; Zhang JG
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1094-1099. PubMed ID: 34695901
[No Abstract] [Full Text] [Related]
12. Human papillomavirus genotypes among females in Mexico: a study from the Mexican institute for social security.
Salcedo M; Pina-Sanchez P; Vallejo-Ruiz V; Monroy-Garcia A; Aguilar-Lemarroy A; Cortes-Gutierrez EI; Santos-Lopez G; Montoya-Fuentes H; Grijalva R; Madrid-Marina V; Apresa-Garcia T; Hernandez DM; Jave-Suarez LF; Romero P; Poot A; Salgado E; Ramos-Gonzalez P; Gonzalez-Hernandez R; Canton JC; Jimenez-Aranda L; Parra-Melquiadez M; Paniagua L; Mendoza M; Arreola H; Villegas V; Torres-Poveda K; Bahena-Roman M; Gonzalez-Yebra B; Taniguchi K; Rodea C; Mantilla-Morales A; Mora-Garcia ML; Velazquez-Velazquez CK; Cordova-Uscanga C; Peralta R; Lopez-Romero R; Marrero D; Bandala C; Reyes-Leyva J; Furuya ME; Almeida E; Galvan ME; Grijalva I
Asian Pac J Cancer Prev; 2014; 15(23):10061-6. PubMed ID: 25556426
[TBL] [Abstract][Full Text] [Related]
13. Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.
Najioullah F; Dorival MJ; Joachim C; Dispagne C; Macni J; Abel S; Sulpicy C; Charpentier-Baltide H; Sainte-Rose D; Salomon-Frechou B; Dieye M; Véronique-Baudin J; Pré M; Marquet M; Wan-Ajouhu G; Janky E; Riethmuller D; Cesaire R;
PLoS One; 2021; 16(10):e0257915. PubMed ID: 34618835
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy.
Mariani L; Monfulleda N; Alemany L; Vizza E; Marandino F; Vocaturo A; Benevolo M; Quirós B; Lloveras B; Klaustermeier JE; Quint W; de Sanjosé S; Bosch FX
BMC Cancer; 2010 Jun; 10():259. PubMed ID: 20525370
[TBL] [Abstract][Full Text] [Related]
17. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
18. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus (HPV) test and PAP smear as predictors of outcome in conservatively treated adenocarcinoma in situ (AIS) of the uterine cervix.
Costa S; Negri G; Sideri M; Santini D; Martinelli G; Venturoli S; Pelusi C; Syrjanen S; Syrjanen K; Pelusi G
Gynecol Oncol; 2007 Jul; 106(1):170-6. PubMed ID: 17481701
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus infection in females with normal cervical cytology: Genotyping and phylogenetic analysis among women in Punjab, Pakistan.
Aziz H; Iqbal H; Mahmood H; Fatima S; Faheem M; Sattar AA; Tabassum S; Napper S; Batool S; Rasheed N
Int J Infect Dis; 2018 Jan; 66():83-89. PubMed ID: 29138009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
